Aprea Therapeutics (APRE) Accounts Payables (2018 - 2026)
Aprea Therapeutics' Accounts Payables was $935,139 in Q2 2026, down 21.8% from $1.2 million a year earlier and down 68.2% from the prior quarter.
Aprea Therapeutics (APRE) Accounts Payables (2018 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Aprea Therapeutics came in at $713,668, down 47.2% from FY2024.
- Accounts Payables shows a five-year compound annual growth rate of -30.8% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $1.35 million in FY2024 (-19.0%), $1.67 million in FY2023 (+98.2%), $842,754 in FY2022 (-52.5%) and $1.77 million in FY2021 (-60.6%).
- Quarterly Accounts Payables has moved between $641,322 (Q3 2025) and $3.99 million (Q2 2022) over five years.
- Compared with a year earlier, Accounts Payables was higher in three of the last eight quarters, with growth averaging 6.5%.
- The best year-over-year quarter for Accounts Payables over five years was Q1 2026 (growth of 129.5%); the worst was Q2 2023 (a decline of 71.6%).
- Per Business Quant data, APRE's Accounts Payables in the three quarters before Q2 2026 was $2.94 million (Q1 2026), $713,668 (Q4 2025) and $641,322 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Aprea Therapeutics | 28.88 Mn | -87.17 Mn | - | 935,139.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 935,139.00 |
| Mar 31, 2026 | 2.94 Mn |
| Dec 31, 2025 | 713,668.00 |
| Sep 30, 2025 | 641,322.00 |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 964,327.00 |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 862,552.00 |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 826,027.00 |
| Dec 31, 2022 | 842,754.00 |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 3.99 Mn |
| Mar 31, 2022 | 1.99 Mn |
| Dec 31, 2021 | 1.77 Mn |
| Sep 30, 2021 | 2.55 Mn |
Aprea Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=APRE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();